TEVA PHARMACEUTICAL INDUSTRIES LTD (27)

Browse by Contract Category

Contracts

Appointment Letter, dated as of July 27, 2021, of Sven Dethlefs (Filed With SEC on February 9, 2022)
Amendment to Employment Agreement between Teva Pharmaceuticals USA, Inc. and Sven Dethlefs, dated as of July 18, 2018 (Filed With SEC on February 9, 2022)
Third Supplemental Senior Indenture, dated as of November 9, 2021, among Teva Pharmaceutical Finance Netherlands III B.V., Teva Pharmaceutical Industries Limited and The Bank of... (Filed With SEC on November 10, 2021)
Appointment Letter, dated as of July 27, 2021, of Mark Sabag (Filed With SEC on February 9, 2022)
Employment Agreement, dated as of June 5, 2018, between Teva Pharmaceuticals USA, Inc. and Sven Dethlefs (Filed With SEC on February 9, 2022)
Third Supplemental Senior Indenture, dated as of November 9, 2021, among Teva Pharmaceutical Finance Netherlands II B.V., Teva Pharmaceutical Industries Limited, The Bank of New... (Filed With SEC on November 10, 2021)
Underwriting Agreement, dated as of November 2, 2021, among the Issuers, the Company, BNP Paribas, BNP Paribas Securities Corp., BofA Securities Europe SA, BofA Securities, Inc.,... (Filed With SEC on November 4, 2021)
Transfer Agreement of Employment Contract, dated as of March 20, 2020, between Teva Sante, Teva Pharmaceutical Industries Limited and Eric Drap (Filed With SEC on February 10, 2021)
Employment Agreement, dated as of May 30, 2013, between Teva Sante and Eric Drap (Filed With SEC on February 10, 2021)
Employment Agreement, dated as of March 12, 2020, between Teva Pharmaceutical Industries Limited and Eric Drap (Filed With SEC on February 10, 2021)
Teva Pharmaceutical Industries Limited Israeli Subplan of Tevas 2020 Long-Term Equity-Based Incentive Plan (Filed With SEC on November 5, 2020)
Form Award Agreement under Tevas 2020 Long-Term Equity-Based Incentive Plan (Filed With SEC on November 5, 2020)
Amendment No. 1 dated as of June 9, 2020, to the Employment Agreement between Teva Pharmaceutical Industries Limited and Kre Schultz (Filed With SEC on June 9, 2020)
Amendment to Employment Agreement between Teva Pharmaceutical Industries Limited and Eli Kalif, dated as of February 6, 2020 (Filed With SEC on February 21, 2020)
Form Award Agreement (RSUs and PSUs) under the Teva Pharmaceutical Industries Limited 2015 Long-Term Equity-Based Incentive Plan (Filed With SEC on February 21, 2020)
Form Award Agreement under the Teva Pharmaceutical Industries Limited 2015 Long-Term Equity-Based Incentive Plan applicable to selected 2016 grants and 2017 grants made to... (Filed With SEC on February 21, 2020)
Form Special Award Letter applicable to selected 2017 grants made to Gianfranco Nazzi and Brendan OGrady (Filed With SEC on February 21, 2020)
Employment Agreement, dated as of November 6, 2019, between Teva Pharmaceutical Industries Limited and Eli Kalif (Filed With SEC on February 21, 2020)
Employment Agreement, dated as of April 1, 2019, between Teva Pharmaceutical Industries Limited and Gianfranco Nazzi (Filed With SEC on February 21, 2020)
Employment Agreement, dated as of December 22, 2013, between Teva Pharmaceuticals USA Inc. and Brendan OGrady (Filed With SEC on February 21, 2020)
Separation Agreement, dated as of November 4, 2019, between Teva Pharmaceuticals USA, Inc. and Carlo de Notaristefani (Filed With SEC on February 21, 2020)
Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 21, 2020)
Second Supplemental Senior Indenture, dated as of November 25, 2019, among Teva Pharmaceutical Finance Netherlands II B.V., Teva Pharmaceutical Industries Limited, The Bank of New... (Filed With SEC on November 25, 2019)
Registration Rights Agreement, dated as of November 25, 2019, among Teva Pharmaceutical Finance Netherlands III B.V., Teva Pharmaceutical Industries Limited and the initial... (Filed With SEC on November 25, 2019)
Second Supplemental Senior Indenture, dated as of November 25, 2019, among Teva Pharmaceutical Finance Netherlands III B.V., Teva Pharmaceutical Industries Limited and The Bank of... (Filed With SEC on November 25, 2019)
Registration Rights Agreement, dated as of November 25, 2019, among Teva Pharmaceutical Finance Netherlands II B.V., Teva Pharmaceutical Industries Limited and the initial... (Filed With SEC on November 25, 2019)
Amendment to Employment Agreement between Teva Pharmaceuticals USA, Inc. and Hafrun Fridriksdottir, dated as of January 4, 2019 (Filed With SEC on February 19, 2019)